Paul H Klingenstein - Net Worth and Insider Trading
Paul H Klingenstein Net Worth
The estimated net worth of Paul H Klingenstein is at least $19 Million dollars as of 2024-09-21. Paul H Klingenstein is the Director of Anacor Pharmaceuticals Inc and owns about 1,809,937 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $18 Million. Paul H Klingenstein is also the Director, 10% Owner of Conatus Pharmaceuticals Inc and owns about 2,279,363 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $1 Million. Details can be seen in Paul H Klingenstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul H Klingenstein has not made any transactions after 2013-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul H Klingenstein
Paul H Klingenstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul H Klingenstein owns 5 companies in total, including Clovis Oncology Inc (CLVSQ) , Anacor Pharmaceuticals Inc (ANAC) , and Histogen Inc (HSTO) among others .
Click here to see the complete history of Paul H Klingenstein’s form 4 insider trades.
Insider Ownership Summary of Paul H Klingenstein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CLVSQ | Clovis Oncology Inc | 2016-06-09 | director |
ANAC | Anacor Pharmaceuticals Inc | 2014-05-29 | director |
HSTO | Histogen Inc | 2013-07-24 | director & 10 percent owner |
2013-05-08 | director | ||
2004-07-28 | 10 percent owner |
Paul H Klingenstein Latest Holdings Summary
Paul H Klingenstein currently owns a total of 2 stocks. Among these stocks, Paul H Klingenstein owns 1,809,937 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 30, 2010, with a value of $18 Million and a weighting of 93.3%. Paul H Klingenstein also owns 2,279,363 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $1 Million and a weighting of 6.7%.
Latest Holdings of Paul H Klingenstein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ANAC | Anacor Pharmaceuticals Inc | 2010-11-30 | 1,809,937 | 9.82 | 17,773,581 |
CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 2,279,363 | 0.56 | 1,276,443 |
Holding Weightings of Paul H Klingenstein
Paul H Klingenstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul H Klingenstein has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the acquisition of 300,000 shares on November 30, 2010, which cost Paul H Klingenstein around $2 Million.
According to the SEC Form 4 filings, Paul H Klingenstein has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 566 shares on July 30, 2013, which brought Paul H Klingenstein around $6,226.
Insider Trading History of Paul H Klingenstein
- 1
Paul H Klingenstein Trading Performance
GuruFocus tracks the stock performance after each of Paul H Klingenstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul H Klingenstein is 57.8%. GuruFocus also compares Paul H Klingenstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul H Klingenstein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul H Klingenstein's insider trading performs compared to the benchmark.
Performance of Paul H Klingenstein
Paul H Klingenstein Ownership Network
Paul H Klingenstein Owned Company Details
What does Clovis Oncology Inc do?
Who are the key executives at Clovis Oncology Inc?
Paul H Klingenstein is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .
Clovis Oncology Inc (CLVSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clovis Oncology Inc Insider Transactions
Paul H Klingenstein Mailing Address
Above is the net worth, insider trading, and ownership report for Paul H Klingenstein. You might contact Paul H Klingenstein via mailing address: 428 University Ave, C/o Accel Partners, Palo Alto Ca 94301.